Overcoming platinum resistance in ovarian cancer by targeting pregnancy-associated plasma protein-A.
<h4>Objectives</h4>Inhibition of pregnancy-associated plasma protein-A (PAPP-A), an upstream activator of the insulin-like growth factor (IGF) pathway, is known to augment sensitivity to platinum-based chemotherapy. This study further tests the efficacy of PAPP-A inhibition with a monocl...
Main Authors: | Diogo Torres, Xiaonan Hou, Laurie Bale, Ethan P Heinzen, Matthew J Maurer, Valentina Zanfagnin, Ann L Oberg, Cheryl Conover, S John Weroha |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0224564 |
Similar Items
-
Ovarian Cancer—Insights into Platinum Resistance and Overcoming It
by: Andrei Havasi, et al.
Published: (2023-03-01) -
Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer
by: Michelle McMullen, et al.
Published: (2020-06-01) -
Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts
by: Kristina A. Butler, et al.
Published: (2017-08-01) -
Editorial: New strategies to overcome platinum resistance in ovarian cancer
by: Jian-Jun Wei, et al.
Published: (2024-03-01) -
Overcoming the challenges of drug development in platinum-resistant ovarian cancer
by: Ramez N. Eskander, et al.
Published: (2023-10-01)